Neon Therapeutics Obtains $55,000,000 Series A Funding Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8a859408-8e80-436b-a73f-a924c95f3631
Date 10/2/2015
Company Name Neon Therapeutics
Mailing Address 215 First Street Cambridge, MA 02142 USA
Company Description We have assembled a team of world experts in cancer immunotherapy to develop therapies that target abnormal proteins called neoantigens, which are produced by cancer cells. Our programs are designed to leverage multiple facets of the immune response to elicit potent immune attack of tumors, with the aim of providing durable response to patients in need.
Proceeds Purposes The contributions from world-leading experts in core scientific advances in neoantigen biology have paved the way for the founding of Neon Therapeutics, and the company plans to work closely with them moving forward to bring new therapies to patients.